Next report date
Report period
Q1 2024
EPS estimate
−1.22CHF
Revenue estimate
23.03 MCHF
−129.33 MCHF
312.53 MCHF
80.46 M
Om CRISPR Therapeutics AG
Sektor
Bransch
VD
Samarth Kulkarni
Webbplats
Huvudkvarter
Zug
Employees (FY)
407
Grundat
2013
FIGI
BBG00LVD6DC2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
